JP2024084670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024084670A5 JP2024084670A5 JP2023090210A JP2023090210A JP2024084670A5 JP 2024084670 A5 JP2024084670 A5 JP 2024084670A5 JP 2023090210 A JP2023090210 A JP 2023090210A JP 2023090210 A JP2023090210 A JP 2023090210A JP 2024084670 A5 JP2024084670 A5 JP 2024084670A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- migalastat
- salt
- patient
- caffeine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263432235P | 2022-12-13 | 2022-12-13 | |
| US63/432,235 | 2022-12-13 | ||
| US18/315,928 US20240197706A1 (en) | 2022-12-13 | 2023-05-11 | Methods of improving the pharmacokinetics of migalastat |
| US18/315,928 | 2023-05-11 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024084670A JP2024084670A (ja) | 2024-06-25 |
| JP2024084670A5 true JP2024084670A5 (enExample) | 2025-04-23 |
| JP7757345B2 JP7757345B2 (ja) | 2025-10-21 |
Family
ID=86646511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023090210A Active JP7757345B2 (ja) | 2022-12-13 | 2023-05-31 | ミガラスタットの薬物動態を改善する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240197706A1 (enExample) |
| EP (1) | EP4385509B1 (enExample) |
| JP (1) | JP7757345B2 (enExample) |
| KR (1) | KR20240094973A (enExample) |
| AU (1) | AU2023396459A1 (enExample) |
| CA (1) | CA3201512A1 (enExample) |
| CL (1) | CL2025001743A1 (enExample) |
| CO (1) | CO2025009079A2 (enExample) |
| DE (1) | DE202023003007U1 (enExample) |
| IL (1) | IL321404A (enExample) |
| MX (1) | MX2025006897A (enExample) |
| TW (1) | TW202423436A (enExample) |
| WO (1) | WO2024129220A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| EP2142197A4 (en) | 2007-03-30 | 2010-11-10 | Amicus Therapeutics Inc | PROCESS FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONS |
| US9999618B2 (en) * | 2007-04-26 | 2018-06-19 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| LT3470077T (lt) | 2008-02-12 | 2021-02-25 | Amicus Therapeutics, Inc. | Atsako į ligų gydymą farmakologiniu šaperonu prognozavimo būdas |
| CN103974619B (zh) * | 2011-03-11 | 2017-02-15 | 阿米库斯治疗学公司 | 治疗法布里病的给药方案 |
| JP2024542023A (ja) * | 2021-11-03 | 2024-11-13 | サンガモ セラピューティクス，インコーポレイテッド | ファブリー病の治療のためのウイルスベクター構築物の使用方法 |
-
2023
- 2023-05-11 US US18/315,928 patent/US20240197706A1/en active Pending
- 2023-05-31 TW TW112120343A patent/TW202423436A/zh unknown
- 2023-05-31 IL IL321404A patent/IL321404A/en unknown
- 2023-05-31 WO PCT/US2023/067656 patent/WO2024129220A1/en not_active Ceased
- 2023-05-31 JP JP2023090210A patent/JP7757345B2/ja active Active
- 2023-05-31 EP EP23176366.5A patent/EP4385509B1/en active Active
- 2023-05-31 AU AU2023396459A patent/AU2023396459A1/en active Pending
- 2023-05-31 DE DE202023003007.2U patent/DE202023003007U1/de active Active
- 2023-05-31 CA CA3201512A patent/CA3201512A1/en active Pending
- 2023-05-31 KR KR1020230070371A patent/KR20240094973A/ko not_active Ceased
-
2025
- 2025-06-12 MX MX2025006897A patent/MX2025006897A/es unknown
- 2025-06-12 CL CL2025001743A patent/CL2025001743A1/es unknown
- 2025-07-03 CO CONC2025/0009079A patent/CO2025009079A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI222879B (en) | Release-controlled pharmaceutical compositions for treating dysfunction of urinary bladder | |
| KR101718639B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| US6376550B1 (en) | Pharmaceutical compositions containing tramadol for migraine | |
| JP2505944B2 (ja) | （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
| ES2797493T3 (es) | Formulaciones farmacéuticas de liberación controlada de nitazoxanida | |
| JPH06102622B2 (ja) | 肥満の治療 | |
| JP2005512995A5 (enExample) | ||
| JP2020529996A5 (enExample) | ||
| US20070105869A1 (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| JP2012136523A (ja) | テルビナフィンを含有する医薬組成物およびその使用 | |
| JP3194734B2 (ja) | 迅速作用性選択的セロトニン再摂取阻害剤を用いた性的不全の処置方法 | |
| JP2013213047A (ja) | にきびの治療方法発明の分野 | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| Plänitz | Comparison of moxonidine and clonidine HCl in treating patients with hypertension | |
| SK284937B6 (sk) | Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény | |
| RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| WO2002078691A1 (en) | Duloxetine for treatment of hot flashes | |
| JP4786127B2 (ja) | 色素沈着改善治療薬 | |
| JP2022177119A5 (enExample) | ||
| JP2024084670A5 (enExample) | ||
| BRPI0609779A2 (pt) | composição farmacêutica oral de liberação controlada, e, método de tratamento da deficiência de hormÈnio da tireóide | |
| JP2665357B2 (ja) | 心不全治療用医薬組成物 | |
| JP2019533672A5 (enExample) | ||
| HUP0200655A2 (hu) | Osanetant alkalmazása kedélyállapot-rendellenességek kezelésére használható gyógyszerek előállítására | |
| RU2002115814A (ru) | Лечение системной красной волчанки с помощью дегидроэпиандростерона |